左心耳封堵术后院外心包积液的危险因素分析

朱世杰, 郑慕晗, 彭健, 等. 左心耳封堵术后院外心包积液的危险因素分析[J]. 临床心血管病杂志, 2023, 39(7): 547-551. doi: 10.13201/j.issn.1001-1439.2023.07.011
引用本文: 朱世杰, 郑慕晗, 彭健, 等. 左心耳封堵术后院外心包积液的危险因素分析[J]. 临床心血管病杂志, 2023, 39(7): 547-551. doi: 10.13201/j.issn.1001-1439.2023.07.011
ZHU Shijie, ZHENG Muhan, PENG Jian, et al. Risk factors of out-of hospital pericardial effusion after left atrial appendage closure[J]. J Clin Cardiol, 2023, 39(7): 547-551. doi: 10.13201/j.issn.1001-1439.2023.07.011
Citation: ZHU Shijie, ZHENG Muhan, PENG Jian, et al. Risk factors of out-of hospital pericardial effusion after left atrial appendage closure[J]. J Clin Cardiol, 2023, 39(7): 547-551. doi: 10.13201/j.issn.1001-1439.2023.07.011

左心耳封堵术后院外心包积液的危险因素分析

详细信息

Risk factors of out-of hospital pericardial effusion after left atrial appendage closure

More Information
  • 目的 探讨左心耳和毗邻结构的距离以及术后心律与左心耳封堵(left atrial appendage closure,LAAC)术后院外心包积液(out-of-hospital pericardial effusion,OHPE)的关系。方法 回顾性纳入2015年5月—2019年5月于南方医科大学南方医院行LAAC的52例患者,其中发生OHPE 12例纳入OHPE组,余40例纳入对照组。利用心血管造影计算机断层扫描(cardiac computed tomography angiography,cCTA)评估左心耳与毗邻结构,包括肺动脉(pulmonary artery,PA)、左上肺静脉(left superior pulmonary vein,LSPV)、左冠状动脉回旋支(left circumflex coronary artery,LCX)的距离。采用多因素logistic回归分析LAAC术后发生OHPE的危险因素,并利用受试者工作特征曲线(receiver operating characteristic curve,ROC)分析危险因素对OHPE的诊断价值。结果 与对照组比较,OHPE组左心耳与PA、LSPV的距离明显减小[PA:(3.6±1.5) mm vs (2.5±1.3) mm,P=0.006;LSPV:(3.2±1.4) mm vs (2.6±1.9) mm,P=0.025];两组左心耳与LCX的距离差异无统计学意义(P=0.157)。多因素回归分析显示,左心耳与PA的距离是LAAC术后发生OHPE的独立保护因素(OR=0.466,95%CI:0.234~0.927,P=0.030)。左心耳与PA的距离预测OHPE的ROC曲线下面积为0.765(95%CI:0.626~0.871,P < 0.01),最佳预测值为2 mm,特异度为90.0%,灵敏度为58.3%。此外,转复窦性心律的患者更易发生OHPE(OR=7.071,95%CI:1.124~44.506,P=0.037)。结论 左心耳与PA的距离可作为LAAC术后OHPE的预测指标,转复窦性心律的患者更容易发生OHPE。
  • 加载中
  • 图 1  左心耳与PA的距离预测OHPE的ROC曲线

    Figure 1.  The ROC curve of OHPE predicted by the distance from left atrial appendage to PA

    表 1  研究对象的临床基线资料

    Table 1.  Clinical baseline data 例(%), X±S

    项目 整体(52例) 对照组(40例) OHPE组(12例) P
    年龄/岁 66.7±8.3 66.4±8.2 67.6±9.3 0.671
    男性 33(63.5) 23(57.5) 10(83.3) 0.198
    BMI/(kg/m2) 24.9±4.3 24.8±4.1 25.0±5.1 0.872
    高血压 36(69.2) 26(65.0) 10(83.3) 0.395
    糖尿病 8(15.4) 4(10.0) 4(33.3) 0.131
    CHA2DS2-VASc评分 4.4±1.8 4.3±1.7 4.8±2.1 0.412
    HAS-BLED评分 2.0±1.1 2.0±1.0 1.9±1.2 0.991
    左心室射血分数/% 59.5±8.0 60.4±7.1 56.6±10.4 0.154
    左心房内径/mm 44.7±6.7 44.4±6.2 45.6±8.5 0.312
    NYHA分级 1.000
      Ⅰ 10(19.2) 8(20.0) 2(16.7)
      Ⅱ 39(75.0) 30(75.0) 9(75.0)
      Ⅲ 3(5.8) 2(5.0) 1(8.3)
    房颤类型 0.811
      阵发性 18(34.6) 13(32.5) 5(41.7)
      持续性 34(65.4) 27(67.5) 7(58.3)
    封堵器类型 0.565
      盖子式 16(30.8) 11(27.5) 5(41.7)
      塞子式 36(69.2) 29(72.5) 7(58.3)
    封堵器尺寸/mm 28.8±3.7 29.0±3.5 28.3±4.3 0.566
    左心耳类型 0.212
      仙人掌型 11(21.2) 10(25.0) 1(8.3)
      鸡翅型 16(30.8) 14(35.0) 2(16.7)
      风向标型 10(19.2) 7(17.5) 3(25.0)
      菜花型 15(28.8) 9(22.5) 6(50.0)
    cCTA测量值/mm
      左心耳开口长轴 28.9±3.8 29.4±3.5 27.2±4.5 0.089
      左心耳开口短轴 22.2±4.8 22.6±4.5 20.6±5.5 0.193
    术式 0.321
      一站式手术 40(76.9) 29(72.5) 11(91.7)
      仅左心耳封堵 12(23.1) 11(27.5) 1(8.3)
    下载: 导出CSV

    表 2  对照组与OHPE组左心耳毗邻结构的距离

    Table 2.  The distance from the left atrial appendage to adjacent structures mm, X±S

    组别 左心耳与PA距离 左心耳与LSPV距离 左心耳与LCX距离
    对照组(40例) 3.6±1.5 3.2±1.4 2.9±1.5
    OHPE组(12例) 2.5±1.3 2.6±1.9 3.4±1.2
    P 0.006 0.025 0.157
    下载: 导出CSV

    表 3  OHPE危险因素的logistic回归分析

    Table 3.  Risk factors of OHPE analyzed by logistic analysis

    项目 单因素 多因素
    OR 95%CI P OR 95%CI P
    糖尿病 4.500 0.924~21.925 0.063 4.639 0.779~27.619 0.092
    左心耳与PA距离 0.463 0.236~0.907 0.025 0.466 0.234~0.927 0.030
    下载: 导出CSV
  • [1]

    Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC)Developed with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498. doi: 10.1093/eurheartj/ehaa612

    [2]

    Beigel R, Wunderlich NC, Ho, SY, et al. The left atrial appendage: anatomy, function, and noninvasive evaluation[J]. JACC Cardiovasc Imaging, 2014, 7(12), 1251-1265.

    [3]

    庞乃栋, 张楠, 郭敏, 等. 左心耳电隔离在持续性心房颤动治疗中的研究进展[J]. 临床心血管病杂志, 2022, 38(1): 6-10. doi: 10.13201/j.issn.1001-1439.2022.01.002 https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.01.002

    [4]

    Reddy VY, Doshi SK, Kar S, et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials[J]. J Am Coll Cardiol, 2017, 70(24): 2964-2975. doi: 10.1016/j.jacc.2017.10.021

    [5]

    Landmesser U, Schmidt B, Nielsen-Kudsk JE, et al. Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study[J]. EuroIntervention, 2017, 13(7): 867-876. doi: 10.4244/EIJ-D-17-00493

    [6]

    Huang H, Liu Y, Xu Y, et al. Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study[J]. JACC Cardiovasc Interv, 2017, 10(21): 2188-2194. doi: 10.1016/j.jcin.2017.06.072

    [7]

    Yang L, Zhang X, Jin Q, et al. Pericardial Effusion During the Perioperative Period for Left Atrial Appendage Closure[J]. Front Cardiovasc Med, 2021, 8: 678460. doi: 10.3389/fcvm.2021.678460

    [8]

    Munir MB, Khan MZ, Darden D, et al. Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17, 700 procedures in the United States[J]. Heart Rhythm, 2021, 18(9): 1508-1515. doi: 10.1016/j.hrthm.2021.05.017

    [9]

    Price MJ, Valderrábano M, Zimmerman S, et al. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry[J]. Circ Cardiovasc Interv, 2022, 15(5): e011718.

    [10]

    Liu B, Luo J, Gong M, et al. Five-Year Outcomes and Cardiac Remodeling Following Left Atrial Appendage Occlusion[J]. Clin Interv Aging, 2021, 16: 655-663. doi: 10.2147/CIA.S296639

    [11]

    段文涛, 张峰, 陈萍, 等. CT血管造影成像与超声心动图在预测非瓣膜性心房颤动患者左心耳血栓形成中的应用[J]. 临床心血管病杂志, 2023, 39(3): 201-207. doi: 10.13201/j.issn.1001-1439.2023.03.009 https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2023.03.009

    [12]

    Korsholm K, Berti S, Iriart X, et al. Expert Recommendations on Cardiac Computed Tomography for Planning Transcatheter Left Atrial Appendage Occlusion[J]. JACC Cardiovasc Interv, 2020, 13(3): 277-292. doi: 10.1016/j.jcin.2019.08.054

    [13]

    Hanazawa K, Brunelli M, Saenger J, et al. Close proximity between pulmonary artery and left atrial appendage leading to perforation of the artery, tamponade and death after appendage closure using cardiac plug device[J]. Int J Cardiol, 2014, 175(2): e35-6. doi: 10.1016/j.ijcard.2014.04.260

    [14]

    Xiao F, Chen Y, Chen Y, et al. Delayed pericardial effusion after left atrial appendage closure with the LAmbre device: Importance of a fully open umbrella[J]. J Cardiovasc Electrophysiol, 2021, 32(6): 1646-1654. doi: 10.1111/jce.15020

    [15]

    Demkow M, Konka M, Witkowski A, et al. How to Prevent Pulmonary Artery Wall Perforation Following Transcatheter Occlusion of Left Atrial Appendage[J]. J Am Soc Echocardiogr, 2021, 34(2): 195-197. doi: 10.1016/j.echo.2020.10.010

    [16]

    Halkin A, Cohen C, Rosso R, et al. Left atrial appendage and pulmonary artery anatomic relationship by cardiac-gated computed tomography: Implications for late pulmonary artery perforation by left atrial appendage closure devices[J]. Heart Rhythm, 2016, 13(10): 2064-2069. doi: 10.1016/j.hrthm.2016.07.015

    [17]

    Zou T, Chen Q, Zhang L, et al. Pulmonary artery pressure is associated with mid-term major adverse cardiovascular events and postprocedure pericardial effusion in atrial fibrillation patients undergoing left atrial appendage occlusion[J]. Ann Transl Med, 2021, 9(16): 1324. doi: 10.21037/atm-21-3561

    [18]

    Kulawiak-Gałąska DA, Gałąska R, Mielczarek M, et al. Pulmonary artery and left atrial appendage anatomical relationship using electrocardiogram——gated computed tomography: An important aspect of left atrial appendage occlusion[J]. Cardiol J, 2021, 28(2): 342-344. doi: 10.5603/CJ.a2021.0024

    [19]

    Li CY, Gao BL, Liu XW, et al. Quantitative Evaluation of the Substantially Variable Morphology and Function of the Left Atrial Appendage and Its Relation with Adjacent Structures[J]. PLoS One, 2015, 10(7): e0126818. doi: 10.1371/journal.pone.0126818

    [20]

    Chun KR, Bordignon S, Urban V, et al. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience[J]. Heart Rhythm, 2013, 10(12): 1792-179. doi: 10.1016/j.hrthm.2013.08.025

    [21]

    杨再鑫, 石亮, 王彦江, 等. 心房颤动射频消融术中活化凝血时间维持在220~270 s的安全性[J]. 临床心血管病杂志, 2022, 38(6): 467-471. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.06.008

  • 加载中

(1)

(3)

计量
  • 文章访问数:  1085
  • PDF下载数:  192
  • 施引文献:  0
出版历程
收稿日期:  2023-03-05
刊出日期:  2023-07-13

目录